Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Indeterminate colitis.

Karel Geboes1, Gert De Hertogh

  • 1Department of Pathology, University Hospital KU Leuven, Leuven, Belgium. Karel.Geboes@uz.kuleuven.ac.be

Inflammatory Bowel Diseases
|October 14, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunosuppression-free Nonvascularized Rectus Fascia Allotransplantation for Complex Hernia Repair.

Transplantation direct·2026
Same author

Histologic and combined histologic-endoscopic outcomes with mirikizumab in Crohn's disease: VIVID-1 trial results.

Journal of Crohn's & colitis·2026
Same author

Multi-omic biomarkers of neoadjuvant treatment response in rectal cancer: A narrative review.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

Young onset rectal cancer (YORC): a descriptive tertiary center analysis.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

Histopathologic Evaluation and Reporting in Inflammatory Bowel Disease: A Consensus Document Sponsored by the Rodger C. Haggitt Gastrointestinal Pathology Society.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

Histological proof of pulmonary herpesvirus presence in patients with COVID-19- or influenza-related ARDS.

Critical care (London, England)·2026
Same journal

Patients with Crohn's disease achieving transmural healing experience superior long-term outcomes compared with those with endoscopic or radiologic healing alone.

Inflammatory bowel diseases·2026
Same journal

Higher body mass index is associated with lower drug concentrations in patients with inflammatory bowel disease treated with ustekinumab but not vedolizumab.

Inflammatory bowel diseases·2026
Same journal

Association of preoperative neoplasia and rectal cuff inflammation on initial pouchoscopy with subsequent neoplasia development in inflammatory bowel disease patients with an ileal pouch-anal anastomosis: a case-control study.

Inflammatory bowel diseases·2026
Same journal

Pediatric bowel-wall thickness cutoffs: calibration before implementation.

Inflammatory bowel diseases·2026
Same journal

Trained immunity: Breaking a dogma and a missing opportunity in IBD?

Inflammatory bowel diseases·2026
Same journal

Response to the letter to the editor: "pediatric bowel-wall thickness cutoffs: calibration before implementation".

Inflammatory bowel diseases·2026
See all related articles

Diagnosing Crohn's disease (CD) and ulcerative colitis (UC) can be challenging. Indeterminate colitis (IC) presents overlapping features, necessitating further investigation into its potential as a distinct entity.

Area of Science:

  • Gastroenterology
  • Pathology
  • Immunology

Background:

  • Distinguishing Crohn's disease (CD) and ulcerative colitis (UC) is complex due to overlapping clinical, histologic, endoscopic, and radiologic features.
  • Indeterminate colitis (IC) was initially defined for surgical specimens with features of both CD and UC.
  • The definition of IC has expanded to encompass chronic inflammatory bowel disease of the colon lacking definitive CD or UC criteria.

Purpose of the Study:

  • To investigate indeterminate colitis (IC) as a potentially separate entity from Crohn's disease (CD) and ulcerative colitis (UC).
  • To explore the distinct clinical and serologic characteristics of IC.
  • To address the diagnostic challenges in differentiating between CD, UC, and IC.

Main Methods:

  • Clinicopathologic diagnosis integrating clinical, endoscopic, radiographic, and histologic data.

Related Experiment Videos

  • Analysis of macroscopic and microscopic features in surgical specimens.
  • Evaluation of clinical characteristics and serologic markers (perinuclear antineutrophil cytoplasmic antibody, anti-Saccharomyces cerevisiae).

    • Main Results:

    • Indeterminate colitis (IC) diagnosis relies on a combination of diagnostic data, similar to CD and UC.
    • IC exhibits distinct clinical characteristics compared to UC.
    • A subset of IC patients shows negative results for serologic markers associated with CD and UC.

    Conclusions:

    • Indeterminate colitis (IC) is a clinicopathologic diagnosis often considered temporary.
    • The distinct clinical and serologic profiles of IC suggest it may represent a separate entity.
    • Further investigation is warranted to confirm IC as a distinct disease entity.